Published in Front Microbiol on April 27, 2016
Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov (2003) 5.48
Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother (2001) 4.89
Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem Photobiol Sci (2004) 4.60
Guideline for Hand Hygiene in Health-Care Settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Infect Control Hosp Epidemiol (2002) 4.26
A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc (2008) 3.46
Photodynamic antimicrobial chemotherapy (PACT). J Antimicrob Chemother (1998) 3.26
Melanized fungi in human disease. Clin Microbiol Rev (2010) 2.89
Physical mechanisms of generation and deactivation of singlet oxygen. Chem Rev (2003) 2.26
Fusariosis, a complex infection caused by a high diversity of fungal species refractory to treatment. Eur J Clin Microbiol Infect Dis (2013) 1.34
Antifungal photodynamic therapy. Microbiol Res (2007) 1.20
The role of singlet oxygen and oxygen concentration in photodynamic inactivation of bacteria. Proc Natl Acad Sci U S A (2007) 1.20
Potential of photodynamic therapy in treatment of fungal infections of the mouth. Design and characterisation of a mucoadhesive patch containing toluidine blue O. J Photochem Photobiol B (2006) 1.07
Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform. Front Microbiol (2012) 1.07
Photosensitizing activity of water- and lipid-soluble phthalocyanines on prokaryotic and eukaryotic microbial cells. Microbios (1992) 1.04
Susceptibility of Candida albicans, Staphylococcus aureus, and Streptococcus mutans biofilms to photodynamic inactivation: an in vitro study. Lasers Med Sci (2010) 1.03
Investigation of the photodynamic effects of curcumin against Candida albicans. Photochem Photobiol (2011) 1.03
Photodynamic antimicrobial chemotherapy (PACT) with methylene blue increases membrane permeability in Candida albicans. Lasers Med Sci (2007) 1.03
Susceptibility of Candida albicans to photodynamic therapy in a murine model of oral candidosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2010) 1.00
The effects of rose bengal- and erythrosine-mediated photodynamic therapy on Candida albicans. Mycoses (2011) 0.96
Photodynamic antifungal chemotherapy. Photochem Photobiol (2012) 0.96
Influence of multidrug efflux systems on methylene blue-mediated photodynamic inactivation of Candida albicans. J Antimicrob Chemother (2011) 0.95
In vitro efficacy of antifungal treatment using riboflavin/UV-A (365 nm) combination and amphotericin B. Invest Ophthalmol Vis Sci (2010) 0.93
Assessment of rose bengal versus riboflavin photodynamic therapy for inhibition of fungal keratitis isolates. Am J Ophthalmol (2014) 0.92
Photodynamic therapy with Pc 4 induces apoptosis of Candida albicans. Photochem Photobiol (2011) 0.92
Fungal biofilms, drug resistance, and recurrent infection. Cold Spring Harb Perspect Med (2014) 0.91
Exophiala dermatitidis endocarditis on native aortic valve in a postrenal transplant patient and review of literature on E. dermatitidis infections. Mycoses (2012) 0.91
Fatal Exophiala infections in China, with a report of seven cases. Mycoses (2010) 0.90
Respiratory deficiency enhances the sensitivity of the pathogenic fungus Candida to photodynamic treatment. Photochem Photobiol (2008) 0.89
Photodynamic inactivation for controlling Candida albicans infections. Fungal Biol (2011) 0.89
Photodynamic therapy for pathogenic fungi. Mycoses (2011) 0.89
High rate of Exophiala dermatitidis recovery in the airways of patients with cystic fibrosis is associated with pancreatic insufficiency. J Clin Microbiol (2011) 0.88
Assessment of fungal viability after long-wave ultraviolet light irradiation combined with riboflavin administration. Graefes Arch Clin Exp Ophthalmol (2012) 0.87
Photodynamic antifungal therapy against chromoblastomycosis. Mycopathologia (2011) 0.87
In vitro photodynamic therapy against Foncecaea pedrosoi and Cladophialophora carrionii. Mycoses (2012) 0.86
Phaeohyphomycosis of the central nervous system in immunocompetent hosts: report of a case and review of the literature. Int J Infect Dis (2003) 0.84
Treatment of refractory fingernail onychomycosis caused by nondermatophyte molds with methylaminolevulinate photodynamic therapy. J Am Acad Dermatol (2011) 0.82
Photodynamic therapy in Pythium insidiosum - an in vitro study of the correlation of sensitizer localization and cell death. PLoS One (2014) 0.81
The impact of absorbed photons on antimicrobial photodynamic efficacy. Front Microbiol (2015) 0.81
Silicon phthalocyanine 4 phototoxicity in Trichophyton rubrum. Antimicrob Agents Chemother (2014) 0.80
Photodynamic therapy for pythiosis. Vet Dermatol (2013) 0.79
Antimicrobial photodynamic therapy: an effective alternative approach to control fungal infections. Front Microbiol (2015) 0.78
In vitro combination therapy using low dose clotrimazole and photodynamic therapy leads to enhanced killing of the dermatophyte Trichophyton rubrum. BMC Microbiol (2014) 0.77
Distal and lateral toenail onychomycosis caused by Trichophyton rubrum: treatment with photodynamic therapy based on methylene blue dye. An Bras Dermatol (2014) 0.77
In vitro photodynamic inactivation of Sporothrix schenckii complex species. Med Mycol (2014) 0.76
In vivo photodynamic inactivation of Candida albicans using chloro-aluminum phthalocyanine. Oral Dis (2016) 0.76
INK128 Exhibits Synergy with Azoles against Exophiala spp. and Fusarium spp. Front Microbiol (2016) 0.75